Clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders

Sectors
Healthcare
Life Sciences
First Invested
2010
Public/PIPES
Company Status
IPO/Public
NASDAQ: RIGL
Associated Team
Paul Walker